Resources for understanding the dangers of drug importation

Nicole Longo   |     March 28, 2017   |   SHARE THIS

Recent proposals to allow drug importation from other countries are dangerous for patients and the U.S. drug supply chain. To better understand how these importation schemes could negatively affect U.S. patients, here are some of the latest resources to keep in your back pocket:

  • Another danger of large-scale importation proposals is an increased risk of counterfeit medicines entering the United States. Take a look at these cases of counterfeit cancer drugs entering the United States and counterfeit hepatitis C drugs found in Switzerland.

You can get information on drug importation and more delivered to your inbox by subscribing to the Catalyst. Stay up to date on drug importation at PhRMA.org/Importation.

Nicole Longo

Nicole Longo Nicole is senior director of public affairs at PhRMA focusing on Medicare, 340B, importation and more. She previously worked for a D.C.-based public affairs firm where she assisted a wide range of clients with communications efforts on everything from trade policy to agriculture policy to health care policy. Outside the office, Nicole can be found trying new restaurants (usually Italian), taking an occasional barre class and cheering on the Cincinnati Bengals.

Topics: Prescription Drug Safety, Drug Importation

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates